UBS Group »

Spero Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Spero Therapeutics (SPRO) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Spero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Spero Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spero Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $483 329 1.47
2023-09-30 $33k 27k 1.20
2023-06-30 $39k 27k 1.45
2023-03-31 $60k 42k 1.45
2022-12-31 $79k 46k 1.73
2022-09-30 $46k 23k 2.00
2022-06-30 $999 755 1.32
2022-03-31 $7.0k 755 9.27
2021-12-31 $520k 33k 15.71
2021-09-30 $530k 29k 18.39
2021-06-30 $27k 1.9k 14.29
2021-03-31 $456k 31k 14.71
2020-12-31 $277k 14k 19.33
2020-09-30 $6.0k 500 12.00
2020-06-30 $79k 6.0k 13.33
2020-03-31 $73k 9.0k 8.14
2019-12-31 $137k 14k 9.60
2019-09-30 $117k 11k 10.59
2019-06-30 $136k 12k 11.52
2018-12-31 $20k 3.2k 6.25
2018-09-30 $25k 2.4k 10.60
2018-06-30 $13k 945 14.20
2018-03-31 $5.0k 496 10.00
2017-12-31 $0 128 0.00